|
T.Yu. Demidova, I.N. Drozdova
Metformin: review of current evidence and international recommendations
|
№2 / 2017
|
|
M.Ye. Statsenko, S.V. Turkina, N.N. Shilina, M.A. Kosivtsova
Potentials for the additional medical correction using cytoprotectors in patients with chronic heart failure and nonalcoholic fatty liver disease
|
№1 / 2017
|
|
T.Yu. Demidova
Oral hypoglycemic therapy in the practice of a general practitioner
|
№6 / 2016
|
|
M.Ye. Statsenko, М.V. Derevyanchenko
Influence of the combined antihypertensive therapy on renal function and insulin resistance in patients with hypertension and type 2 diabetes
|
№5 / 2016
|
|
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
|
№5 / 2016
|
|
T.Yu. Demidova
Sulfonylurea derivatives in the light of evidence-based medicine and algorithms of diabetes mellitus type 2
|
№4 / 2016
|
|
I.V. Druk, Ye.A. Ryapolova
Metformin: updated guidance and pleiotropic potential
|
№4 / 2016
|
|
Ye.I. Baranova, Ye.A. Polyakova
Antihypertensive therapy in patients with prediabetes and diabetes mellitus type 2
|
№3 / 2016
|
|
I.V. Poluboyarinova, V.V. Fadeev
A new look at the effects of metformin
|
№1 / 2016
|
|
L.V. Nedosugova
Current place of metformin in the treatment of type 2 diabetes
|
№4 / 2015
|
|
T.Yu.Demidova, I.N. Drozdova
Efficacy and safety of the DPP-4 inhibitor saxagliptin in the treatment of type 2 diabetes
|
№4 / 2015
|
|
M.E. Statsenko, S.V. Turkina
Algorithm of differential prescription of cytoprotectors in patients with chronic heart failure and disorders of carbohydrate metabolism
|
№3 / 2015
|
Русский
